Larimar Therapeutics's total assets for Q4 2025 were $145.84M, a decrease of -22.16% from the previous quarter. LRMR total liabilities were $67.76M for the fiscal quarter, a 40.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.